Infratil Limited Stocks

A$ 10.02Last Updated 29.04.2026

Issuer Rating

4/7
Performance

Average

Risk

Limited

Recommendation

Hold

Market Cap

A$ 7.21B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
A$ 10.02
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Infratil Limited owns and operates infrastructure businesses and investments primarily in New Zealand, Australia, the United States, Asia, the United Kingdom, and Europe. The company supplies electricity to commercial and industrial customers; develops, owns, and generates renewable energy; develops utility-scale wind and solar generation throughout North America; develops wind, solar PV energy projects, and storage solutions; and provides outsourced data center services to government and commercial entities, as well as develops and operates data centers. It also owns and manages a portfolio of commercial real estate properties; operates retirement living units and apartments; operates airport; and provides finance services. In addition, the company offers mobile subscription, broadband connection, TV connection services; and diagnostic imaging, a service for various health applications, including x-rays, ultrasound, CT scans, PET scans, and MRIs which are used to prevent, diagnose, and treat a range of diseases and other health issues, such as cardiovascular, musculoskeletal, respiratory, hearing/vision, neurological, kidney, gastrointestinal, and cancer. It owns and operates 27 hydro power stations with a total installed capacity of 498 MW. The company was incorporated in 1994 and is based in Wellington, New Zealand.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Somewhat favourable
5/7

The average target price of IFT.AX is 12 and suggests 21% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increa

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks